InStar creates high value differentiated opportunities by:
- Developing product addressing unmet therapeutics needs
- Pursuing high technological barrier product
- Identifying unique repurposing opportunities
- Providing lifecycle management opportunities
| Indication | R&D | in vitro/ex vivo | validation | prelinical | clinical | launch |
| Migraines | ||||||
| NSAID's | ||||||
| Protein Diabetes | ||||||
| Albumin | ||||||
| Dietary supplement | ||||||
| Erectile dysfunction | ||||||
| Flavonoids |